Iradimed Co - Asset Resilience Ratio
Iradimed Co (IRMD) has an Asset Resilience Ratio of 0.00% as of December 2022. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2012–2022)
This chart shows how Iradimed Co's Asset Resilience Ratio has changed over time. Check strategic asset allocation of Iradimed Co to assess the company's strategic physical and investment asset allocation.
Liquid Assets Composition Over Time
This chart breaks down Iradimed Co's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see IRMD stock market capitalisation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $0.00 | 0% |
| Total Liquid Assets | $0.00 | 0.00% |
Asset Resilience Insights
- Limited Liquidity: Iradimed Co maintains only 0.00% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company maintains a balanced mix of cash and short-term investments.
Iradimed Co Industry Peers by Asset Resilience Ratio
Compare Iradimed Co's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Bio-Rad Laboratories Inc
NYSE:BIO |
Medical Devices | 10.80% |
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 12.59% |
|
Tellgen Corp
SHE:300642 |
Medical Devices | 9.96% |
|
Affluent Medical SAS
PA:AFME |
Medical Devices | 0.03% |
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
Anteris Technologies Global Corp
AU:AVR |
Medical Devices | 33.27% |
|
Imricor Medical Systems Inc
AU:IMR |
Medical Devices | 46.50% |
|
Polynovo Ltd
AU:PNV |
Medical Devices | 0.04% |
Annual Asset Resilience Ratio for Iradimed Co (2012–2022)
The table below shows the annual Asset Resilience Ratio data for Iradimed Co.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2022-12-31 | 0.00% | $0.00 | $85.51 Million | -- |
| 2021-12-31 | 0.61% | $501.86K | $82.88 Million | -2.08pp |
| 2020-12-31 | 2.69% | $1.91 Million | $71.07 Million | -1.46pp |
| 2019-12-31 | 4.15% | $2.77 Million | $66.73 Million | -8.96pp |
| 2018-12-31 | 13.11% | $6.35 Million | $48.44 Million | -7.74pp |
| 2017-12-31 | 20.85% | $8.14 Million | $39.01 Million | -0.56pp |
| 2016-12-31 | 21.42% | $7.97 Million | $37.19 Million | -0.15pp |
| 2015-12-31 | 21.57% | $7.60 Million | $35.24 Million | -12.38pp |
| 2014-12-31 | 33.95% | $7.91 Million | $23.31 Million | +30.43pp |
| 2013-12-31 | 3.52% | $246.20K | $6.99 Million | -0.99pp |
| 2012-12-31 | 4.52% | $250.79K | $5.55 Million | -- |
About Iradimed Co
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible intravenous infusion pump systems and MRI compatible patient vital signs monitoring systems and related accessories. The company offers MRidium 3870 and 3860+ MRI Compatible IV Infusion Pump System with associated disposable IV tubing sets; 3880 MRI compatible patient vital signs moni… Read more